Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance

被引:105
作者
Jabra-Rizk, Mary Ann
Shirtliff, Mark
James, Cathy
Meiller, Timothy
机构
[1] Univ Maryland, Sch Dent, Dept Diagnost Sci & Pathol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Dent, Dept Pathol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Dent, Dept Biomed Sci, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
关键词
farnesol; fluconazole resistance; biofilm; Candida dubliniensis; Candida albicans;
D O I
10.1111/j.1567-1364.2006.00121.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Candida dubliniensis and Candida albicans are dimorphic fungal species with a number of pathogenic capabilities, including biofilm formation, systemic infection and development of fluconazole resistance. In this study, the ability of farnesol to disrupt these virulence capabilities was investigated. Biofilm assessment and susceptibility studies indicated antifungal and antibiofilm properties for farnesol on both species with a disruptive effect on the cell membrane. Synergy testing of farnesol and fluconazole in resistant strains resulted in reversal of fluconazole resistance, indicating a potential application for farnesol as an adjuvant therapeutic agent.
引用
收藏
页码:1063 / 1073
页数:11
相关论文
共 63 条
[1]   Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents [J].
Baillie, GS ;
Douglas, LJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (03) :397-403
[2]   Role of dimorphism in the development of Candida albicans biofilms [J].
Baillie, GS ;
Douglas, LJ .
JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (07) :671-679
[3]  
Baillie GS, 1999, METHOD ENZYMOL, V310, P644
[4]   Adherence of different Candida dubliniensis isolates in the presence of fluconazole [J].
Borg-von Zepelin, M ;
Niederhaus, T ;
Gross, U ;
Seibold, M ;
Monod, M ;
Tintelnot, K .
AIDS, 2002, 16 (09) :1237-1244
[5]   Candida dubliniensis Fungemia:: the first four cases in North America [J].
Brandt, ME ;
Harrison, LH ;
Pass, M ;
Sofair, AN ;
Huie, S ;
Li, RK ;
Morrison, CJ ;
Warnock, DW ;
Hajjeh, RA .
EMERGING INFECTIOUS DISEASES, 2000, 6 (01) :46-49
[6]   Sensitization of Staphylococcus aureus and Escherichi coli to antibiotics by the sesquiterpenoid nerolidol, farnesol, bisabolol, and apritone [J].
Brehm-Stecher, BF ;
Johnson, EA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3357-3360
[7]  
BROWN DM, 2000, J PEDIAT DENT, V22, P234
[8]   cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol [J].
Cao, YY ;
Cao, YB ;
Xu, Z ;
Ying, K ;
Li, Y ;
Xie, Y ;
Zhu, ZY ;
Chen, WS ;
Jiang, YY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :584-589
[9]   Antifungal resistance of candidal biofilms formed on denture acrylic in vitro [J].
Chandra, J ;
Mukherjee, PK ;
Leidich, SD ;
Faddoul, FF ;
Hoyer, LL ;
Douglas, LJ ;
Ghannoum, MA .
JOURNAL OF DENTAL RESEARCH, 2001, 80 (03) :903-908
[10]   Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance [J].
Chandra, J ;
Kuhn, DM ;
Mukherjee, PK ;
Hoyer, LL ;
McCormick, T ;
Ghannoum, MA .
JOURNAL OF BACTERIOLOGY, 2001, 183 (18) :5385-5394